Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
1
20%
Ph phase_2
3
60%
Ph phase_3
1
20%

Phase Distribution

0

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
3(60.0%)
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(3)
Other(1)

Detailed Status

Completed3
Active, not recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 23 (60.0%)
Phase 31 (20.0%)
N/A1 (20.0%)

Trials by Status

active_not_recruiting120%
completed360%
unknown120%

Recent Activity

1 active trials
Showing 5 of 5
active_not_recruitingphase_2

NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy

NCT06024031
unknownphase_3

Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution

NCT03967665
completedphase_2

Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation

NCT03236220
completednot_applicable

High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure

NCT02718079
completedphase_2

The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain

NCT01840345

Clinical Trials (5)

Showing 5 of 5 trials
NCT06024031Phase 2

NAC for Promoting Hematopoietic Recovery in Patients With Acute Myeloid Leukemia After Chemotherapy

Active Not Recruiting
NCT03967665Phase 3

Risk Stratification-directed NAC for Prevention of Poor Hematopoietic Reconstitution

Unknown
NCT03236220Phase 2

Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation

Completed
NCT02718079Not Applicable

High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure

Completed
NCT01840345Phase 2

The Role of N-acetyl-l-cysteine (NAC) as an Adjuvant to Opioid Treatment in Patients With Chronic Neuropathic Pain

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5